Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Show more...
執行長
Dr. Vidar Wendel-Hansen M.D., Ph.D.
員工
2
國家
SE
ISIN
SE0020678159
WKN
000A3EJG7
上市
0 Comments
分享你的想法
FAQ
Quia Pharma AB 今天的股價是多少?▼
99B0.F 目前價格為 €0 EUR,過去 24 小時下跌了 -50%。在圖表上更密切關注 Quia Pharma AB 股票的表現。
Quia Pharma AB 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Quia Pharma AB 的股票以代號 99B0.F 進行交易。
Quia Pharma AB 的股價在上漲嗎?▼
99B0.F 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Quia Pharma AB 上漲 +0%。